A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Natarajan, Rama, Ph.D, F.A.H.A, F.A.S.N. Research

Rama Natarajan, Ph.D, F.A.H.A, F.A.S.N. Research
The major focus of our research is to determine the cellular and molecular mechanisms that play key roles in the development of diabetic vascular complications. We use genomic, transcriptomic and epigenomic approaches in cell culture, animal and clinical models to examine our hypothesis that accelerated vascular complications result from enhanced vascular and renal cell growth, and also monocyte activation due to altered expression of inflammatory cytokines, chemokines and lipids under diabetic conditions.
We are actively evaluating molecular mechanisms involved in the expression of pathological genes under diabetic conditions and in promoting metabolic memory. We have demonstrated the role of specific chromatin histone posttranslational modifications in the epigenetic regulation of inflammatory genes. We use epigenomic profiling approaches to map histone modifications, DNA methylation and binding of chromatin factors at diabetes-regulated genes with techniques such as Chromatin immunoprecipitation (ChIP) assays, ChIP-linked to microarrays, and ChIP-Sequencing. We have uncovered key epigenetic alterations under diabetic conditions in vitro, in vivo in diabetic mice, and in cells from diabetic patients, and shown relevance to the phenomenon of metabolic memory.
Another active area is the evaluation of specific microRNAs in regulating the expression of inflammatory and fibrotic genes under diabetic conditions. We are examining various mechanisms of microRNA regulation, performing expression profiling using RNA-sequencing, and studying how key microRNAs co-operate with each other in a circuit to amplify the effects of growth factors under diabetic conditions. To test the functional significance in the kidney, we are generating microRNA knockout mice and also evaluating novel modified inhibitors of specific microRNAs (antagomirs) on the progression of diabetic kidney disease in mouse models.

Lab Members

Rama Natarajan, Ph.D., F.A.H.A, F.A.S.N.
National Office Products Endowed Professor
626-256-HOPE (4673), ext. 62289
Marpadga A. Reddy, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 63671
Feng Miao, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 65575
Mitsuo Kato, Ph.D.
Assistant Research Professor
626-256-HOPE (4673), ext. 63996
Kirti Bhatt, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 65811
Nancy Castro, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 64690
Ye Jia, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 62289
Amy Leung, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 62278
Jung-tak Park, M.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 64809
Hang Yuan, Ph.D.
Postdoctoral Fellow
626-256-HOPE (4673), ext. 65817
Supriya Deschpande
Graduate Student
626-256-HOPE (4673), ext. 65835
Wen Jin
Graduate Student
626-256-HOPE (4673), ext. 65823
Linda Lanting, B.S.
Research Associate
626-256-HOPE (4673), ext. 64692
Mei Wang, M.S.
Research Associate
626-256-HOPE (4673), ext. 64676
Lingxiao Zhang, M.S.
Research Associate
626-256-HOPE (4673), ext. 65571
Nancy (Zhuo) Chen
Bioinformatics Specialist
656-256-HOPE (4673), ext. 65058
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. Bridget’s doctors told her she only had a year to live. Then she met neurosurgeon Dr. Behnam Badie. That was 5 years ago. The cancer grows...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • News about the risks or benefits of widespread cancer screening seem to arrive daily – 3D mammography for breast cancer, CT scans for lung cancer, PSA tests for prostate cancer and now pelvic exams for some women’s cancers. Missing in the headlines is a reflection of how cancer detection is evolving. Today’s ca...
  • Adults with sickle cell disease soon may have a new treatment option: bone marrow transplants. Children with sickle cell disease have been treated successfully with transplantation of bone marrow, more officially known as hematopoietic stem cells, from other people. But the procedure has been less successful in...
  • New pelvic exam recommendations or not, women shouldn’t give up those routine gynecological appointments. The revised guidelines from the American College of Physicians exempt most women from pelvic examinations, but a cancer specialist at City of Hope says women should still plan on regular visits with t...
  • Scientists have long searched for ways to bolster the immune system to fight diseases that seem to evade it, including cancer. Many have focused on monoclonal antibodies, trying to use them as trucks to drop off payloads of drugs right at the site of an infection or tumor. The problem, however, has been welding...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • Music makes a difference – in patient mood and in patient healing. To that end, patient care at City of Hope now has a special new program called the Musicians On Call Jason Pollack Bedside Performance Program, which brings live, in-room performances to patients undergoing treatment or unable to leave their hos...
  • Vaccinating people against hepatitis B could prevent diabetes from developing in some individuals, a new City of Hope study suggests. The study, an analysis of the National Health and Nutrition Examination Survey, indicated that people vaccinated for hepatitis B had a 50 percent reduction in risk for diabetes c...
  • Treatments for kidney cancer have improved dramatically in recent years, with new therapies already in use and others on the near horizon. The need has never been greater: Incidence rates for kidney cancer are rising. This year, nearly 64,000 new cases of kidney cancer will be diagnosed in the United States, an...
  • It is mid-afternoon on a Sunday at the cosmetics counter at Macy’s. A woman approaches with smiling eyes and dewy skin in a crisp white lab coat. I feel at ease as she offers me a seat. With a soft touch she applies eye makeup and powder to my forehead and chin. She is charming, […]
  • John Cloer became a teenager in May, an ordinary rite of passage made extraordinary because he is a cancer survivor – one of an estimated 370,000 pediatric cancer survivors in the U.S. He was three months shy of his third birthday in 2004 when what his parents Bill and Gina Cloer assumed was the flu was diagnos...